MarketPulse

short seller report

11 articles
GlobeNewswire Inc.GlobeNewswire Inc.··The Rosen Law Firm

ADMA Biologics Stock Plunges 16.6% After Channel Stuffing Allegations

ADMA Biologics ($ADMA) stock crashed 16.6% following channel stuffing allegations. Rosen Law Firm launches investigation into securities fraud claims.
ADMAsecurities fraudclass action lawsuit
The Motley FoolThe Motley Fool··Jennifer Saibil

SoFi Under Fire: What Q1 Earnings Must Reveal About Loan Quality Claims

SoFi faces critical April 29 earnings test following short-seller allegations of overstating profits and understating loan losses by as much as 90%.
SOFIshort seller reportfinancial engineering
The Motley FoolThe Motley Fool··Eric Volkman

Poet Technologies Stock Plunges 8% After Wolfpack Research Levels Stock Promotion Allegations

Poet Technologies stock fell 8% following Wolfpack Research's report alleging stock promotion schemes, questionable practices, and minimal earnings generation since 2020.
POETstock declineinfluencer marketing
GlobeNewswire Inc.GlobeNewswire Inc.··Portnoy Law Firm

Securities Investigation Launched Into NUAI Over Alleged Promotion Spending and Management History

Portnoy Law Firm investigates NUAI for potential securities fraud following short seller allegations of excessive promotional spending and CEO's troubled track record.
NUAINUAIWsecurities fraudclass action
GlobeNewswire Inc.GlobeNewswire Inc.··Kirby Mcinerney Llp

Soleno Therapeutics Faces Federal Securities Lawsuit Over Drug Safety Misrepresentations

Federal class action filed against $SLNO over alleged safety misrepresentations of DCCR drug. Stock fell 39% after safety revelations; investor deadline May 5, 2026.
SLNOsecurities class actionlead plaintiff deadline
BenzingaBenzinga··Kaustubh Bagalkote

MakeMyTrip Faces Short-Seller Attack Over Alleged Regulatory Violations, Accounting Gaps

Short-seller Morpheus Research alleges MakeMyTrip violates CCI orders, employs accounting gimmicks, and loses market share amid customer safety concerns.
BKNGPCLNEXPEMMYTaccounting concernsshort seller report
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

ADMA Biologics Plunges 16% as Short Seller Alleges Channel Stuffing Scheme

ADMA Biologics shares crashed 16% after short seller accused the company of inflating revenues through improper rebates and extended payment terms to distributors.
ADMAsecurities fraudbiopharmaceutical
The Motley FoolThe Motley Fool··Jack Delaney

Two Beaten-Down Stocks Offer Potential Bargains for Long-Term Investors

SoFi and Sirius XM, both facing significant headwinds, offer potential bargains for patient investors seeking long-term growth and value appreciation opportunities.
SOFISIRIfintechvaluation
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

Soleno's VYKAT XR Faces Legal Storm as Safety Concerns Tank Stock 40%

Soleno Therapeutics faces securities lawsuit after hyperphagia drug VYKAT XR launch falters amid safety concerns, driving shares down 40% since August short seller report.
SLNOstock declinesecurities class action
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

Soleno Therapeutics Hit With Class Action Over VYKAT Launch Failures and Safety Disclosures

$SLNO faces securities lawsuit alleging misleading safety claims for hyperphagia drug VYKAT XR. Stock crashed 40% after short seller report and management admissions of launch disruptions.
SLNOsecurities class actionclinical trial
GlobeNewswire Inc.GlobeNewswire Inc.··The Rosen Law Firm

Rosen Law Firm Launches Investigation Into NUAI Following Short Seller Allegations

Rosen Law Firm investigates NUAI following short seller allegations of questionable spending priorities and CEO's penny stock history. Stock fell 6.9%.
NUAINUAIWsecurities fraudclass action lawsuit